# BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection

> **NCT01641016** · PHASE2,PHASE3 · UNKNOWN · sponsor: **PENTA Foundation** · enrollment: 160 (estimated)

## Conditions studied

- HIV

## Interventions

- **DRUG:** efavirenz

## Key facts

- **NCT ID:** NCT01641016
- **Lead sponsor:** PENTA Foundation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2014-06
- **Final completion:** 2016-06
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2015-03-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01641016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01641016, "BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01641016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*